| Value | ₹2.12 Cr |
|---|---|
| Execution period | 30 days from completion of agreed conditions |
BSE filing, NSE: KIRLOSELEC. Summary written from the filing by ALFA Finder's alert engine.
Envair Electrodyne Ltd: key numbers
- Share price
- ₹46.15
- Market cap
- ₹21.41 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.11 Cr
- P/E (TTM)
- 21365.7×Sector 52.2×
- Promoter holding
- 57.52%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Envair Electrodyne Ltd
All →Envair Electrodyne Other Announcement
Envair Electrodyne Ltd filed its quarterly shareholding pattern under Regulation 31 for the period ended September 30, 2026.
Envair Electrodyne Annual General Meeting
Envair Electrodyne Limited conducted its 44th Annual General Meeting on September 29, 2026. Shareholders adopted audited financial statements and approved the re-appointment of directors and statutory auditors.
Envair Electrodyne Annual General Meeting
Envair Electrodyne Ltd shareholders approved the sale/disposal of its overseas investment in Alliance Asia Pac Pte. Ltd., Singapore, via a postal ballot.
Envair Electrodyne Annual Report
Envair Electrodyne Ltd has filed its 44th Annual Report for the financial year 2025-26 and notice for the upcoming Annual General Meeting.
Envair Electrodyne Annual General Meeting
Envair Electrodyne Ltd announced the outcome of its board meeting, scheduling the 44th Annual General Meeting for September 29, 2026. The board also approved the AGM notice and related reports.
Envair Electrodyne Annual General Meeting
Envair Electrodyne Limited has issued a postal ballot notice to seek shareholder approval for selling its overseas investment in Alliance Asia Pac Pte. Ltd., Singapore.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr